Clinical Trials Logo

Rheumatoid Arthritis Shoulder clinical trials

View clinical trials related to Rheumatoid Arthritis Shoulder.

Filter by:
  • None
  • Page 1

NCT ID: NCT05926622 Recruiting - Avascular Necrosis Clinical Trials

Clinical and Radiological Outcomes of Medacta Shoulder System FR

Start date: March 15, 2022
Phase:
Study type: Observational

This is a post-marketing surveillance on Medacta Shoulder System

NCT ID: NCT05868148 Recruiting - Rotator Cuff Tears Clinical Trials

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

SiD
Start date: October 20, 2023
Phase:
Study type: Observational

The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in adult patients who have a functional deltoid muscle and massive and non-repairable rotator cuff tear. The main questions it aims to answer are: - What is the average improvement in patient-reported shoulder function after 2 years when compared to before the surgery, and - What is the rate of surgical revisions needed over a 10 year period Patients will be asked to will be asked to regularly attend their check-up visits with their surgeon (including having x-rays or CT images taken to check their shoulder and implant), to complete questionnaires to report how their shoulder is doing, and to tell their surgeon when they notice any changes.

NCT ID: NCT05128500 Active, not recruiting - Psoriatic Arthritis Clinical Trials

Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis

Start date: July 12, 2019
Phase:
Study type: Observational

This observational study is conducted in order to evaluate the effectiveness of the primary total shoulder arthroplasty with the Permedica's MIRAI Modular Shoulder Prosthesis System on the general population of patients who are about to undergo this surgery for every indication. Patients requiring a revision shoulder arthroplasty will not be enrolled. The effectiveness will be evaluated in terms of recovery of shoulder function and stability of the prosthetic implant. The incidence of complications, adverse and serious adverse events will also be studied. Additional study aim is to evaluate a medium/long term survival of the prosthesis. The duration of the study per single subject is 5 years.

NCT ID: NCT05002959 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

TESS V3 Modular Total Shoulder System PMCF

Start date: February 1, 2022
Phase:
Study type: Observational

This is a multicenter, retrospective and prospective, non-controlled post market surveillance study. The objectives of this study are to confirm safety, performance and clinical benefits of the T.E.S.S.® Version 3 Anatomic and Reverse Modular Total shoulder prosthesis and its instrumentation.

NCT ID: NCT05002335 Recruiting - Avascular Necrosis Clinical Trials

Clinical and Radiological Outcomes of Medacta Shoulder System (BE)

Start date: October 6, 2020
Phase:
Study type: Observational

This is a post-market surveillance study on Medacta Shoulder System

NCT ID: NCT04968405 Recruiting - Clinical trials for Osteoarthritis Shoulder

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

Start date: July 22, 2022
Phase: N/A
Study type: Interventional

Evaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.

NCT ID: NCT03547947 Recruiting - Avascular Necrosis Clinical Trials

Clinical and Radiological Outcomes of Medacta Shoulder System

Start date: June 13, 2018
Phase:
Study type: Observational

This is a post-marketing surveillance on Medacta Shoulder System

NCT ID: NCT02029469 Terminated - Clinical trials for Rheumatoid Arthritis Shoulder

Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study

Start date: October 2007
Phase: N/A
Study type: Interventional

It is a non-randomized, consecutive enrollment, 10-year follow-up study of patients who are treated with the Ascension® HRA. Its purpose is to measure and document the outcomes associated with implanting the Ascension HRA prosthesis. Patients will be periodically assessed to collect data related to safety and effectiveness endpoints at the following intervals: preoperative, surgery/immediate post-op, 3 months, 6 months, 1 year, 2 year, 5 year, and 10 years.